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  
To the editor, 
Immune dysregulation, polyendocrinopathy, enteropathy, X-linked (IPEX) syndrome 
is a rare primary immunodeficiency (PID) due to mutations in the FOXP3 gene which is 
located at Xp11.23 [1]. FOXP3 encodes the 431-amino acid transcriptional regulator protein 
forkhead box p3 (Foxp3) that is critical for the development and maintenance of CD3+CD4+ 
CD25+ Foxp3+ regulatory T cells (Tregs) [2]. Mutations in the Treg master transcription 
factor, Foxp3, effects Treg development and function which culminates in multiple 
autoimmune conditions forming the clinical IPEX syndrome [3].  IPEX patients usually 
present in infancy with the clinical triad of enteropathy, autoimmune endocrinopathies and 
dermatitis, although many other autoimmune phenomenon have been reported [4]. 
Pregnancy presents an immunological challenge to the human body with maternal and 
fetal exposure to polymorphic allogeneic foreign antigens from tissues. Fetal tissue has 
immunogenic potential for the mother and requires rapid development of feto-maternal 
tolerance. Acquisition of this tolerance during pregnancy was thought to be solely reliant on 
maternal tolerance of an allogeneic fetus. Evidence now shows that both mother and fetus 
must develop tolerance to allogeneic antigens for successful gestation [5]. Tregs play a 
central role in this process and studies of fetal Tregs show that they possess potent 
lymphocyte suppressor activity [6]. 
Carneiro-Sampaio and colleagues describe two families with fetal-onset IPEX and 
proband males presenting with symptoms of classical IPEX syndrome [7]. Most IPEX cases 
previously reported have uneventful gestations and are born at birth without incident, but a 
detailed family history may reveal miscarriages in previous generations [4].We present a case 
of a mother with a novel FOXP3 mutation and recurrent male miscarriages with no male 
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fetus surviving the beyond the second gestational trimester. With the lack of a proband with 
clinical symptoms of IPEX this case demonstrates the benefits of rapid next generation 
sequencing (NGS) technologies for analysis of PID genes in the diagnosis of challenging 
clinical presentations. 
A 41yr old female was referred for assessment following multiple male miscarriages. 
The patient has a background of atopic dermatitis, asthma, allergic rhinoconjuctivitis and 
irritable bowel syndrome; although she had not undergone endoscopic or histological 
evaluation. There was no previous family history to suggest PID. Blood tests showed normal 
full blood counts, lymphocyte subset populations; CD3+ CD4+ CD25
high
 CD127
low
 Treg 
percentage was 3.6% of total CD3+ CD4+ T cells. IgE was raised at 291 iu/ml. Viral IgG 
serology was detected to CMV, Parvovirus, Rubella and was negative for HIV. She was 
blood group O+ with no anti-erythrocyte antibodies detected. Thyroid function tests were 
normal and there was no history of diabetes. No organ specific autoantibodies were detected. 
The patient’s first pregnancy aged 34yrs resulted in the death of a male fetus at 18 weeks due 
to hydrops fetalis. A limited post-mortem did not identifying any obvious gross 
abnormalities. Aged 35yrs, the patient gave birth to a healthy female at full term. Aged 37yrs, 
a 3
rd
 pregnancy resulted in a male with fatal hydrops fetalis at 20 weeks. Fetal histology 
showed CD3+CD4+ cellular infiltrate within the kidneys and liver. Skeletal muscle was 
almost completely replaced by fibrosis tissue and macrophages. A 4
th
 pregnancy aged 39yr 
resulted in a male fetus with fetal akinesia, progressive hydrops and termination at 18 weeks. 
Fetal histology showed near absent skeletal muscle with reactive CD3+ T cell infiltrating the 
pancreas, myocardium, portal tracts, oesophagus and choroid plexus (Figure 1). PCR on 
histological samples for CMV, Parvovirus B19 and Toxoplasma was negative. Fetal DNA 
screening was performed by next generation sequencing (NGS) with library preparation using 
a Sure Select XT kit with sequencing via Illumina MiSeq, with confirmation by Sanger 
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Sequencing. The mutation FOXP3 c.1009C>T p.(Arg337Ter) was identified in fetal tissue of 
the 3
rd
 and 4
th
 miscarriages. Carrier status of p. Arg337Ter, with random X inactivation, was 
confirmed in the mother. Samples were unavailable from the 1
st
 miscarriage, but the 
similarities are suggestive that the FOXP3 mutation was also present. The patient’s daughter 
remains well and given her age genetic analysis has not yet been undertaken. 
The miscarriage timing in of the miscarriages in the second trimester is possibly due 
to the immunological events occurring at that gestational stage. The second trimester is the 
first time that the fetus is significantly challenged by its own endogenous immune system 
with the requirement for robust self-tolerance. This immunological hurdle is usually met by 
an increase of CD4+ CD25+ Foxp3+ fetal Tregs in peripheral fetal lymphoid organs to 
approximately 15-20% of total CD4+ cells, the highest Treg proportion of CD4+ T cells ever 
during life [8]. In this case we believe that compromise in fetal Treg development due to 
FOXP3c.1009C>T p.(Arg337Ter) caused lethal in utero reactive T cell infiltration of 
multiple organs leading to fetal kinesia and progressive hydrops. The mutation c.1009C>T is 
located in exon 10 of FOXP3 (Genbank accession number NM_014009.3 and results in 
termination of the Foxp3 protein translation at p.(Arg337) with loss of the 94-amino acids 
that form the forkhead domain and C-terminus. The arginine residue at amino acid position 
337 of Foxp3 is highly conserved and involved in binding to DNA [9] and the majority of 
FOXP3 mutations that cause IPEX syndrome are located within the forkhead domain, 
supporting that this region of the protein is critical to its function [4].  
Recently, recurrent male miscarriages with no surviving fetus and a similar clinical 
and histological picture have been reported [10]. However, fetal akinesia and has not been 
described in cases of IPEX syndrome and is usually associated with defects in the 
neuromuscular pathway which complicated the differential diagnosis in our case. Given this 
atypical in utero presentation, the approach of a NGS gene panel allowed multiple genes to 
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be sequenced in a short time for a molecular diagnosis to be quickly achieved. This can then 
offer the opportunity for antenatal testing in subsequent pregnancies. This case furthers 
demonstrates the uses of genomic medicine in patients and families affected by PID. 
Acknowledgements We thank the Regional Molecular Genetics Laboratory, Great Ormond 
Street Hospital, UK for their work with the genetic analysis. 
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Figure 1. (A) Fetal pancreatic tissue with dense predominantly CD3+CD4+ lymphoid 
inflammatory. (B) Fetal myocardial tissue with lymphocytic inflammatory infiltration and 
scattered macrophages (x200 magnification). 
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 IPEX syndrome is recognised to manifest clinically in utero. 
 IPEX syndrome should be considered in cases of recurrent male miscarriage with fetal 
akinesia. 
 The mutation FOXP3 c.1009C>T p.(Arg337Ter) causes severe in utero IPEX syndrome. 
 Next generation sequencing of gene panels can aid diagnosis in atypical presentations of 
primary immunodeficiency. 
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